SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Satchel Paige
| Patient | Satchel Paige |
|---|
| Date of birth | 1953-07-07 |
|---|
| Identifiers | MRN HR-ML047-SYN; SSN (made up) 000-47-3381 |
|---|
| Document date | 2026-07-14 |
|---|
| Author | Delphine Whitaker-Osei, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Visit
Establishing primary care for two years of breathlessness on exertion and a morning cough: history, examination, blood tests including alpha-1 antitrypsin and eosinophils, ECG, NT-proBNP, cardiovascular risk, vaccines, a reliever inhaler and a pulmonology consultation [S]
History of Present Illness
This fictional modern episode addresses the presenting concerns below. [S]
- Breathless on stairs and on walks he used to take easily. [S]
- He wants straight answers and his own numbers, and to be treated the same as anyone else. [S]
- He wants to keep fishing and speaking to young people. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Leroy Robert Page was born in Mobile, Alabama, and was delivered at home by a midwife; his mother was a washerwoman and his father a gardener. The family later changed the spelling of the name to Paige. His accepted date of birth is July 7, 1906. [D]
- His age was disputed for most of his career. He told stories that kept it uncertain, among them that his birth certificate had been kept in a Bible that the family goat ate; later he did not argue with the evidence for July 7, 1906. One historian suggests he was probably born earlier, with the date altered to make him more marketable. [R]
- In 1918, at twelve, he was convicted of shoplifting and sentenced to five years in the Alabama Reform School for Juvenile Negro Law-Breakers, a segregated reform school; he was released at the end of 1923 and began his professional career soon after. [D]
- Because organized baseball had excluded Black players since 1889, he spent his prime in the Negro leagues and on barnstorming tours from 1927 to 1947, pitching for clubs in Chattanooga, Birmingham, Baltimore, Cleveland, Pittsburgh and Kansas City. Black players on tour were barred from the hotels and restaurants used by white people, and he refused to play in towns where he could not get a room or a meal. [D]
- In the late 1930s he developed arm trouble for the first time; after an arm injury in 1938 the Kansas City Monarchs signed him, and his arm recovered the following year. [D]
- In July 1948, at 42, he made his major league debut for the Cleveland Indians, the oldest rookie in the major leagues, and helped them win the 1948 World Series. He pitched his last major league game for the Kansas City Athletics in 1965 at 59, and in 1968 joined the Atlanta Braves as a coach so that he could qualify for a major league pension. [D]
- In 1971 he was the first Negro leagues player elected to the National Baseball Hall of Fame, as the first choice of its Committee on Negro Baseball Leagues. [D]
- He married Janet Howard in 1934. He later married Lahoma Brown, and together they raised seven children in Kansas City, where he lived for most of his adult life. [D]
- In his later years he had emphysema and heart trouble. [D]
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| 1938 | Arm trouble from the late 1930s, with an arm injury in 1938; recovered the next year | D (CLM-0005) |
| In his later years (date not recorded) | Emphysema and heart trouble in his later years; onset, diagnosis and treatment not recorded | D (CLM-0009) |
Family History
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
Social History
- Retired professional pitcher who starred for two decades in the Negro leagues, was kept out of the major leagues until 42 by the exclusion of Black players, pitched in the majors into his late fifties, and is in the Hall of Fame; still speaks at schools and community events [S]
- Lives in Kansas City with his wife; seven grown children, several nearby [S]
- Synthetic smoking history: smoked cigarettes from about 20, roughly three-quarters of a pack a day, about 30 pack-years, and stopped on his own eleven years ago; no vaping; no cannabis. A beer on a holiday (AUDIT-C 1) [S]
- Walks to the corner store and back most days, stopping twice to catch his breath; used to fish; no stairs at home except the porch [S]
- Grew up poor in segregated Mobile and spent five years of his boyhood in a segregated reform school; long experience of being barred from hotels and restaurants on the road; distrustful of being judged by race, and wants his care explained and his numbers shown to him [S]
- Strengths: extraordinary physical discipline over a very long career, humor, a gift for storytelling, a close family and wide community respect [S]
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Albuterol 90 micrograms per inhalation metered-dose inhaler with a spacer, two inhalations every four hours as needed for breathlessness | Two inhalations with a spacer every 4 hours as needed | Respiratory tract route | 2026-07-14 | active | S |
| Atorvastatin 20 mg tablet once a day | One tablet each evening | Oral route | 2026-07-14 | active | S |
Review of Systems
Positive for the concerns in the history of present illness. Alert, witty and guarded at first; mood good but frustrated at being slowed; PHQ-9 5 with item 9 scored 0; no thoughts of self-harm. No other systems reported as affected in this synthetic episode. [S]
General Status
Alert and engaged. Independent in daily activities; breathless after one flight of stairs or a block on the level (mMRC 2); has cut back on fishing trips and on speaking engagements that involve walking. [S]
Physical Exam
Vital signs recorded on 2026-07-14; see the Vital Signs section. Mental status: Alert, witty and guarded at first; mood good but frustrated at being slowed; PHQ-9 5 with item 9 scored 0; no thoughts of self-harm. The physical examination is limited to the findings relevant to this synthetic episode. [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-07-14 | Body height | 191 | cm | S |
| 2026-07-14 | Body weight | 82.6 | kg | S |
| 2026-07-14 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 2026-07-14 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-07-14 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-07-14 | Heart rate | 84 | /min | S |
| 2026-07-14 | Respiratory rate | 18 | /min | S |
| 2026-07-14 | Body temperature | 36.7 | Cel | S |
| 2026-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-07-14 | Hemoglobin [Mass/volume] in Blood | 15.2 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-07-14 | Leukocytes [#/volume] in Blood by Automated count | 7.1 | 10*3/uL | 3.8-10.8 10*3/uL | Normal | S |
| 2026-07-14 | Eosinophils [#/volume] in Blood by Automated count | 0.08 | 10*3/uL | For COPD treatment decisions: below 0.10 argues against an inhaled corticosteroid; 0.30 or more favors one | Normal | S |
| 2026-07-14 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma | 142 | mg/dL | 90-200 mg/dL | Normal | S |
| 2026-07-14 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-146 mmol/L | Normal | S |
| 2026-07-14 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 2026-07-14 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 2026-07-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 71 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-07-14 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 65-99 mg/dL | Normal | S |
| 2026-07-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | <=5.6% | Normal | S |
| 2026-07-14 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 9-46 U/L | Normal | S |
| 2026-07-14 | Cholesterol [Mass/volume] in Serum or Plasma | 224 | mg/dL | <=199 mg/dL | High | S |
| 2026-07-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-07-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 148 | mg/dL | <=99 mg/dL | High | S |
| 2026-07-14 | Triglyceride [Mass/volume] in Serum or Plasma | 160 | mg/dL | <=149 mg/dL | High | S |
| 2026-07-14 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 92 | pg/mL | Below 125 pg/mL makes heart failure unlikely in an outpatient | Normal | S |
| 2026-07-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | | | S |
| 2026-07-14 | Total score [AUDIT-C] | 1 | {score} | | | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Breathlessness on exertion for about two years, now after one flight of stairs or a block on the level (mMRC 2), with a morning cough and a little clear sputum most days; no chest pain, ankle swelling, orthopnea, wheeze at rest or weight loss; a former smoker of about 30 pack-years; cause under evaluation with spirometry and a pulmonology consultation | active | confirmed |
R06.09 | S — Synthetic presenting problem anchored to his documented emphysema; superseded when spirometry at the consultation confirmed COPD. |
| Former cigarette smoker, about 30 pack-years, stopped eleven years ago on his own; no use since | active | confirmed |
Z87.891 | S — Synthetic smoking history: whether he smoked is not documented in the sources read, so the history is synthetic and labeled as such. |
| Hyperlipidemia: LDL 148 mg/dL, HDL 44 and triglycerides 160 at intake; estimated 10-year cardiovascular risk about 18 percent; atorvastatin started by shared decision | active | confirmed |
E78.5 | S — Synthetic cardiovascular risk factor anchored to his documented heart trouble; not a claim about his real lipids. |
Assessment
- Breathlessness on exertion for about two years, now after one flight of stairs or a block on the level (mMRC 2), with a morning cough and a little clear sputum most days; no chest pain, ankle swelling, orthopnea, wheeze at rest or weight loss; a former smoker of about 30 pack-years; cause under evaluation with spirometry and a pulmonology consultation: active, confirmed [S]
- Former cigarette smoker, about 30 pack-years, stopped eleven years ago on his own; no use since: active, confirmed [S]
- Hyperlipidemia: LDL 148 mg/dL, HDL 44 and triglycerides 160 at intake; estimated 10-year cardiovascular risk about 18 percent; atorvastatin started by shared decision: active, confirmed [S]
Plan of Treatment
- Breathlessness work-up at intake: symptoms with the CAT and mMRC, exacerbation history over the past year, smoking history and examination; blood count with eosinophils, alpha-1 antitrypsin once, kidney function, HbA1c, lipids, NT-proBNP and a 12-lead ECG; resting oxygen saturation read with care in darker skin. Guideline: Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025); Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement (2023); CMID: Clinical Monitoring Intelligence Database, COPD and hyperlipidemia monographs (2026) [S]
- Pulmonology consultation to confirm the diagnosis with spirometry, interpret it with race-neutral equations, and advise on treatment, oxygen and rehabilitation. Guideline: Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025); Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement (2023) [S]
- Albuterol with a spacer as needed for breathlessness, with technique checked at the visit. Guideline: Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025) [S]
- Cardiovascular risk: moderate-intensity atorvastatin by shared decision, with a lipid panel at about eight weeks; blood pressure at each visit; ECG reviewed after any exacerbation. Guideline: Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022) [S]
- Vaccines: PCV20 and Tdap now; influenza, RSV and COVID-19 in the autumn; recombinant zoster. Guideline: Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025); Adult Immunization Schedule by Age (2026) [S]
- Referral to pulmonology, Marcus Lindqvist-Bello, MD, ordered 2026-07-14 [S]